Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication

Area of Science:

• * Virology
• * Molecular Biology
• * Hepatology

Background:

• * Hepatitis E virus (HEV) is a significant cause of acute hepatitis globally.
• * Viral replication often hijacks host cell machinery, but specific HEV dependencies are unclear.
• * The eukaryotic translation initiation factors 4F (eIF4F) complex regulates mRNA-ribosome binding and is crucial for many viral replication cycles.

Purpose of the Study:

• * To investigate the role of eukaryotic translation initiation factor 4A (eIF4A), eukaryotic translation initiation factor 4G (eIF4G), and eukaryotic translation initiation factor 4E (eIF4E) in HEV replication.
• * To explore the impact of negative regulatory factors (PDCD4, 4E-BP1) on HEV replication.
• * To determine the involvement of eIF4E phosphorylation and the effect of antiviral drugs (ribavirin, IFN-α) on the eIF4F complex in HEV.

Main Methods:

• * Assessed the requirement of eIF4A, eIF4G, and eIF4E for HEV replication.
• * Evaluated the anti-HEV activities of programmed cell death 4 (PDCD4) and eIF4E-binding protein 1 (4E-BP1).
• * Investigated the role of eIF4E phosphorylation and the interaction of ribavirin and interferon-α (IFN-α) with the eIF4F complex.

Main Results:

• * Efficient HEV replication necessitates eIF4A, eIF4G, and eIF4E.
• * PDCD4 and 4E-BP1 demonstrated anti-HEV activities, confirming the importance of eIF4A and eIF4E.
• * eIF4E phosphorylation by MNK1/2 is not involved in HEV replication; however, eIF4E silencing enhances the efficacy of ribavirin and IFN-α.

Conclusions:

• * The eIF4F complex is essential for HEV replication.
• * Targeting components of the eIF4F complex presents a promising avenue for novel HEV antiviral therapies.
• * Understanding these host-pathogen interactions can guide the development of more effective Hepatitis E treatments.